Amendment No. 1 to Share Purchase Agreement between iBio, Inc. and Eastern Capital Limited
This amendment updates the original Share Purchase Agreement between iBio, Inc. and Eastern Capital Limited for the sale of 6,500,000 shares of iBio's common stock. The amendment changes the deadline referenced in the agreement from March 31, 2016, to April 15, 2016. All other terms of the original agreement remain unchanged.
Exhibit 10.1
AMENDMENT NO. 1
TO
SHARE PURCHASE AGREEMENT
This Amendment No. 1 (this “Amendment”) to the Share Purchase Agreement, dated January 13, 2016 (the “Share Purchase Agreement”), by and among iBio, Inc., a Delaware corporation (the “Company”) and Eastern Capital Limited, a Cayman Islands corporation (including its successors and assigns, the “Purchaser”) for the sale and purchase of 6,500,000 shares of common stock of the Company, is made and entered into as of February 25, 2016.
The Share Purchase Agreement is hereby amended as follows:
1. | The references to “March 31, 2016” in Section 4.3 and Section 5.1(a) of the Share Purchase Agreement are replaced with “April 15, 2016”. |
2. | All other terms and conditions of the Share Purchase Agreement shall remain in full force and effect. |
[Signature Page Follows]
IN WITNESS WHEREOF, this Amendment No. 1 to the Share Purchase Agreement is duly executed as of the date first above written.
IBIO, INC. | |||
By: | /s/ Robert B. Kay | ||
Name: | Robert B. Kay | ||
Title: | Executive Chairman and CEO | ||
EASTERN CAPITAL LIMITED | |||
By: | /s/ Mark VanDevelde | ||
Name: | Mark VanDevelde | ||
Title: | Director | ||